Found 241 matching trials
A Study of Rebif® in Subjects With Relapsing Multiple Sclerosis PHASE4 This is an open-label, multi-center, 12-week, randomized, controlled, paral...
Show More Location
Please contact the Merck KGaA Communication Center
Learn More & Join Trial
Evaluate the Safe and Effective Use of the Avonex® Single-Use Autoinjector in Multiple Sclerosis Subjects PHASE3 The primary objective of the study was to evaluate the safe and effective u...
Show More Learn More & Join Trial
Combination Therapy Using Cellcept and Rebif in RRMS EARLY_PHASE1 The purpose of this trial is to examine the benefits of early combination o...
Show More Location
The Ohio State University Multiple Sclerosis Center
Learn More & Join Trial
Open Label Study of Tolerability, Pharmacokinetics and Pharmacodynamics of BCD-054 (Pegylated Interferon Beta-1a), IM and SC, Compared to Rebif® and Avonex® in Healthy Volunteers PHASE1 This is an international multicenter study of tolerability, pharmacokinetic...
Show More Learn More & Join Trial
Tolerability of Rebif® (Interferon-beta 1-A) Therapy in Korean Patients With Multiple Sclerosis N/A This is an observational study to assess the tolerability of Rebif treatmen...
Show More Location
Samsung Medical Center
Learn More & Join Trial
the Investigation Into Beneficial Effects of High-dose Interferon Beta 1-a, Compared to Low-dose Interferon Beta 1-a in Moderate to Severe Covid-19 PHASE2 The present study is a randomized clinical trial, with the approval of the ...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis PHASE3 To evaluate the safety and efficacy of fingolimod vs. interferon beta-1a i....
Show More Status
Active Not Recruiting
Location
UAB Childrens Hospital Harbor Center Neurology Dept
Learn More & Join Trial
Phase 3 Efficacy and Safety Study of BG00012 in Pediatric Participants With Relapsing-Remitting Multiple Sclerosis (RRMS) PHASE3 The main objectives of Part 1 are as follows: To evaluate the safety, toler...
Show More Location
Boston Children's Hospital
Learn More & Join Trial
Simvastatin as an Add-on Treatment to Interferon-beta-1a for the Treatment of Relapsing-Remitting Multiple Sclerosis PHASE4 This study is to find out if there is any benefit to adding Simvastatin to ...
Show More Location
Coordinating Research Site
Learn More & Join Trial
Avonex (Interferon-beta-1a) and Avonex Plus Methylprednisolone for the Treatment of Relapsing-remitting MS PHASE4 The primary objective of this study is to determine whether combination tre...
Show More Location
CUB Hôpital Erasme
Learn More & Join Trial